- Home
- CRVS vs CHCT Comparison
CRVS vs CHCT Comparison
Compare CRVS & CHCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- CHCT
- Stock Information
- Founded
- CRVS 2014
- CHCT 2014
- Country
- CRVS United States
- CHCT United States
- Employees
- CRVS N/A
- CHCT N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- CHCT Real Estate Investment Trusts
- Sector
- CRVS Health Care
- CHCT Real Estate
- Exchange
- CRVS Nasdaq
- CHCT Nasdaq
- Market Cap
- CRVS 459.0M
- CHCT 425.5M
- IPO Year
- CRVS 2016
- CHCT 2015
- Fundamental
- Price
- CRVS $7.59
- CHCT $14.47
- Analyst Decision
- CRVS Strong Buy
- CHCT Buy
- Analyst Count
- CRVS 4
- CHCT 2
- Target Price
- CRVS $13.75
- CHCT $18.00
- AVG Volume (30 Days)
- CRVS 1.0M
- CHCT 225.1K
- Earning Date
- CRVS 11-04-2025
- CHCT 10-28-2025
- Dividend Yield
- CRVS N/A
- CHCT 13.06%
- EPS Growth
- CRVS N/A
- CHCT N/A
- EPS
- CRVS N/A
- CHCT N/A
- Revenue
- CRVS N/A
- CHCT $119,547,000.00
- Revenue This Year
- CRVS N/A
- CHCT $6.73
- Revenue Next Year
- CRVS N/A
- CHCT $6.07
- P/E Ratio
- CRVS N/A
- CHCT N/A
- Revenue Growth
- CRVS N/A
- CHCT 2.96
- 52 Week Low
- CRVS $2.54
- CHCT $13.23
- 52 Week High
- CRVS $10.00
- CHCT $20.87
- Technical
- Relative Strength Index (RSI)
- CRVS 58.78
- CHCT 50.81
- Support Level
- CRVS $6.81
- CHCT $13.95
- Resistance Level
- CRVS $7.96
- CHCT $14.71
- Average True Range (ATR)
- CRVS 0.52
- CHCT 0.35
- MACD
- CRVS -0.03
- CHCT 0.10
- Stochastic Oscillator
- CRVS 67.50
- CHCT 83.78
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About CHCT Community Healthcare Trust Incorporated
Community Healthcare Trust Inc is an integrated healthcare real estate company in the United States. The company owns and acquires, or finances, real estate properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers in non-urban markets. The company derives majority of its revenues from its real estate property and mortgage notes portfolio. The company's rental and mortgage interest income is recognized based on contractual arrangements with its tenants and borrowers.